A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations

MLA

Klaus Korn, et al. “A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations.” Antimicrobial Agents and Chemotherapy, vol. 59, Apr. 2015, pp. 2062–71. EBSCOhost, https://doi.org/10.1128/aac.04534-14.

APA

Klaus Korn, Hanife Bahsi, Isabel Zeitträger, Manfred Marschall, Anke Unger, Sabrina Wagner, Bert Klebl, Corina Hutterer, Gunther Zischinsky, Carsten Degenhart, Jens Milbradt, Alexander E.H. Wolf, Jan Eickhoff, & Matthias Baumann. (2015). A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations. Antimicrobial Agents and Chemotherapy, 59, 2062–2071. https://doi.org/10.1128/aac.04534-14

Chicago

Klaus Korn, Hanife Bahsi, Isabel Zeitträger, Manfred Marschall, Anke Unger, Sabrina Wagner, Bert Klebl, et al. 2015. “A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations.” Antimicrobial Agents and Chemotherapy 59 (April): 2062–71. doi:10.1128/aac.04534-14.